Citation Impact
1 by Nobel laureates 43 standout
Citing Papers
HER2-targeted therapies in cancer: a systematic review
2024 Standout
Bispecific antibody drug conjugates: Making 1+1>2
2024 Standout
Works of Pascal Chanu being referenced
Exposure-safety and exposure-efficacy analyses of polatuzumab vedotin in patients with relapsed or refractory diffuse large B-cell lymphoma
2020
Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancer
2019
Author Peers
| Author | Oncology | PRM | PFM | Epidemiology | Hepatology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| Pascal Chanu | 133 | 50 | 35 | 98 | 73 | 27 | 383 | |
| K. van der Hoef | 1 | 2 | 10 | 311 | ||||
| B. L. Jhanwar | 7 | 23 | 484 | |||||
| Eleonora Toffoletti | 70 | 15 | 41 | 21 | 19 | 317 | ||
| Sina Reiter | 12 | 713 | ||||||
| William R. Polk | 24 | 182 |
All Works
Login with ORCID to disown or claim papers
Loading papers...